240 related articles for article (PubMed ID: 17132748)
1. The incidence of second primary tumors in thyroid cancer patients is increased, but not related to treatment of thyroid cancer.
Verkooijen RB; Smit JW; Romijn JA; Stokkel MP
Eur J Endocrinol; 2006 Dec; 155(6):801-6. PubMed ID: 17132748
[TBL] [Abstract][Full Text] [Related]
2. Thyroid carcinoma presenting in childhood or after treatment of childhood malignancies: An institutional experience and review of the literature.
Gow KW; Lensing S; Hill DA; Krasin MJ; McCarville MB; Rai SN; Zacher M; Spunt SL; Strickland DK; Hudson MM
J Pediatr Surg; 2003 Nov; 38(11):1574-80. PubMed ID: 14614703
[TBL] [Abstract][Full Text] [Related]
3. Risk of second primary malignancy after radioactive iodine treatment for differentiated thyroid carcinoma.
Bhattacharyya N; Chien W
Ann Otol Rhinol Laryngol; 2006 Aug; 115(8):607-10. PubMed ID: 16944659
[TBL] [Abstract][Full Text] [Related]
4. Differentiated thyroid cancer in a Swedish county--long-term results and quality of life.
Malterling RR; Andersson RE; Falkmer S; Falkmer U; Niléhn E; Järhult J
Acta Oncol; 2010 May; 49(4):454-9. PubMed ID: 20092427
[TBL] [Abstract][Full Text] [Related]
5. [Differentiated thyroid cancers].
Gorgone S; Campennì A; Calbo E; Catalfamo A; Sciglitano P; Sofia L; Niceta M; Borzì R; Calbo L
G Chir; 2009; 30(1-2):26-9. PubMed ID: 19272228
[TBL] [Abstract][Full Text] [Related]
6. The risk of second primary malignancy is increased in differentiated thyroid cancer patients with a cumulative (131)I dose over 37 GBq.
Khang AR; Cho SW; Choi HS; Ahn HY; Yoo WS; Kim KW; Kang KW; Yi KH; Park DJ; Lee DS; Chung JK; Cho BY; Park YJ
Clin Endocrinol (Oxf); 2015 Jul; 83(1):117-23. PubMed ID: 25115234
[TBL] [Abstract][Full Text] [Related]
7. Differentiated thyroid cancer in children: Heterogeneity of predictive risk factors.
Russo M; Malandrino P; Moleti M; Vermiglio F; D'Angelo A; La Rosa G; Sapuppo G; Calaciura F; Regalbuto C; Belfiore A; Vigneri R; Pellegriti G
Pediatr Blood Cancer; 2018 Sep; 65(9):e27226. PubMed ID: 29768715
[TBL] [Abstract][Full Text] [Related]
8. Metastatic differentiated thyroid carcinoma: clinicopathological profile and outcome in an iodine deficient area.
Mishra A; Mishra SK; Agarwal A; Das BK; Agarwal G; Gambhir S
World J Surg; 2002 Feb; 26(2):153-7. PubMed ID: 11865341
[TBL] [Abstract][Full Text] [Related]
9. Estimation of Second Primary Cancer Risk After Treatment with Radioactive Iodine for Differentiated Thyroid Carcinoma.
Corrêa NL; de Sá LV; de Mello RC
Thyroid; 2017 Feb; 27(2):261-270. PubMed ID: 27762670
[TBL] [Abstract][Full Text] [Related]
10. Thyroid remnant 131I ablation for papillary and follicular thyroid carcinoma.
Mazzaferri EL
Thyroid; 1997 Apr; 7(2):265-71. PubMed ID: 9133698
[TBL] [Abstract][Full Text] [Related]
11. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
[TBL] [Abstract][Full Text] [Related]
12. [Relapse of differentiated thyroid carcinoma in low-risk patients].
Krajewska J; Czarniecka A; Jarzab M; Kukulska A; Hankiewicz-Junak D; Hasse-Lazar K; Gubała E; Puch Z; Paliczka E; Roskosz J
Endokrynol Pol; 2006; 57(4):386-91. PubMed ID: 17006841
[TBL] [Abstract][Full Text] [Related]
13. Increased incidence of papillary thyroid cancer detection among thyroidectomies in Greece between 1991 and 2006.
Griniatsos J; Tsigris C; Kanakis M; Kaltsas G; Michail O; Dimitriou N; Argyrakopoulou G; Delladetsima I; Kyriakou V; Syriou V; Alexandraki K; Pikoulis E; Giannopoulos A; Kouraklis G; Diamanti-Kandaraki E; Felekouras E
Anticancer Res; 2009 Dec; 29(12):5163-9. PubMed ID: 20044632
[TBL] [Abstract][Full Text] [Related]
14. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis.
Sampson E; Brierley JD; Le LW; Rotstein L; Tsang RW
Cancer; 2007 Oct; 110(7):1451-6. PubMed ID: 17705176
[TBL] [Abstract][Full Text] [Related]
15. [Primary hyperparathyroidism in patients treated for non-medullary thyroid carcinoma].
Rubello D; Pagetta C; Pelizzo MR; Casara D
Minerva Endocrinol; 2001 Mar; 26(1):31-4. PubMed ID: 11323565
[TBL] [Abstract][Full Text] [Related]
16. Differentiated thyroid carcinoma in childhood and adolescence-clinical course and role of radioiodine.
Chow SM; Law SC; Mendenhall WM; Au SK; Yau S; Mang O; Lau WH
Pediatr Blood Cancer; 2004 Feb; 42(2):176-83. PubMed ID: 14752883
[TBL] [Abstract][Full Text] [Related]
17. [Prospective therapy study in differentiated thyroid carcinoma].
Gemsenjäger E; Heitz P; Martina B
Schweiz Med Wochenschr; 1995 Nov; 125(46):2226-36. PubMed ID: 8525342
[TBL] [Abstract][Full Text] [Related]
18. Differentiated thyroid carcinoma in childhood.
Travagli JP; Schlumberger M; De Vathaire F; Francese C; Parmentier C
J Endocrinol Invest; 1995 Feb; 18(2):161-4. PubMed ID: 7629389
[No Abstract] [Full Text] [Related]
19. [Limited radical approach in differentiated thyroid gland cancers. A prospective study of 107 patients].
Engel U; Kucharski A; Zornig C
Chirurg; 1994 Dec; 65(12):1095-8; discussion 1098-9. PubMed ID: 7851141
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant external-beam radiotherapy in patients with high-risk well-differentiated thyroid cancer.
Chen PV; Osborne R; Ahn E; Avitia S; Juillard G
Ear Nose Throat J; 2009 Jul; 88(7):E01. PubMed ID: 19623515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
